MedTrace Logo

Observational and Prospective Registry on Cardiac Contractility Modulation (CCM) Therapy

NCT04902079 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-06-03

No results posted yet for this study

Summary

Observational and perspective study with acute and chronic endpoint.

Conditions

  • Heart Failure, Systolic

Interventions

DEVICE

Device for Cardiac Contractility Modulation Therapy (CCM)

Evaluate the effect from CCM Therapy in HF population

Sponsors & Collaborators

  • Monaldi Hospital

    lead OTHER

Principal Investigators

  • Antonio D'Onofrio, MD · Ao dei Colli - Monaldi Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-08
Primary Completion
2022-06-30
Completion
2023-12-31
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04902079 on ClinicalTrials.gov